Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Multimodal Sensor Integration and Signal Fusion Engineering

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks integration of multiple sensing modalities into a unified platform designed for real-time pharmaceutical inspection, emphasizing synchronized signal correlation and advanced noise reduction techniques. The project requires the engineering of a robust system capable of fusing data from diverse sensor types to enhance detection accuracy, reliability, and speed in identifying product defects or anomalies during manufacturing processes. Development must ensure temporal and spatial alignment of signals, adaptive filtering for environmental and operational interference, and seamless interoperability across hardware and software components to support continuous, high-fidelity monitoring. This subcontract, under NAICS code 541714 and sponsored by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, targets innovation in sensor fusion technologies with a specific focus on quality assurance in pharmaceutical production. The place of performance is designated as Washington DC with a zip code of 20005, and proposals must be submitted by August 20, 2026. The initiative aims to advance detection capabilities beyond conventional single-sensor approaches, enabling next-generation inspection systems that meet stringent regulatory standards through data-driven, real-time analytics.

General Info

Integrate multi-sensor data for real-time pharmaceutical defect detection with advanced noise reduction and synchronized analytics in Washington DC by August 20, 2026.

Agency

Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)View Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

DC, 20005, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Integrate multiple sensing modalities into a unified platform with real-time signal correlation, synchronization, and noise reduction for pharmaceutical inspection.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Combines Synopsis Solicitation- iPSC DifferentiatiThe National Institutes of Health, through its Office of the Director and Office of Acquisitions, is seeking to award a firm fixed-price contract on a non-competitive basis to Oxford StemTech Ltd of Oxford, UK, for scientific support services related to the quality control of induced pluripotent stem cells and the generation and characterization of organoids using a subset of these cell lines. This acquisition is conducted under streamlined commercial item procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603, 41 U.S.C. 1901, and FAR 6.302-3(a)(2)(ii). The solicitation, identified by number 75N98026Q00878, serves as both the notice of intent and the sole solicitation document, eliminating the need for a separate formal request. The contract is classified under NAICS code 541714 and is being procured without competition due to the unique technical capabilities required and the specialized nature of the services. The response deadline for proposals is July 31, 2026, at 6:00 p.m. Eastern Time, with the posting date listed as July 27, 2026. All submissions must be directed to the designated point of contact, John R. Johnson, reachable via email at johnsonjr@mail.nih.gov, with the contract performance to be carried out in Bethesda, Maryland. The contract will be executed under the authority of the Department of Health and Human Services, and no set-asides or small business preferences are applicable. The offering entity, Oxford StemTech Ltd, has been identified as the only qualified source capable of delivering the required services, justifying the non-competitive approach under the specified regulatory exceptions.
National Institutes Of Health Olao

POSTED

2 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Research service necessary to execute a NAMRU SOUTH Zika study in Panama.Naval Medical Research Unit South is seeking research services to support its Virology Department’s febrile and respiratory surveillance study, specifically in support of a Zika virus study in Panama. The government has conducted market research and determined that only Fundacion Ciudad del Saber possesses the unique capability to fully meet the technical and operational requirements of the study, making the procurement eligible for a sole source award under FAR 13.106-1(b)(i). No competitive solicitation exists, and this notice serves solely as an opportunity for other potential vendors to demonstrate their capability to perform the work. Interested parties must submit a capability statement not exceeding five pages in 10-point font or larger, containing detailed management, technical, and cost information with convincing evidence of their ability to fulfill the requirement. Submissions must be sent via email as a Word or PDF attachment to genaro.m.vasquez.ln@health.mil with the subject line “ERP PR_1301393620” no later than 12:00 PM local time on August 11, 2026. Responses consisting only of questions or requests for clarification will not be accepted. The government retains full discretion to proceed with a sole source award or open a competitive process based on the submissions received. The contracting office is located in Washington, DC, and the primary point of contact is Genaro Vasquez.
Naval Medical Research Unit South

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 541714
New
Federal
Humanized Antibody Library Screening and Transferrin Receptor DevelopmentThe contract involves the customized screening of a humanized antibody library to develop a functional transferrin receptor, encompassing molecular design, in vitro selection, and optimization of binding affinity and specificity. The work requires advanced techniques in antibody engineering to identify and refine candidates capable of high-affinity, selective interaction with the transferrin receptor, with the goal of producing a therapeutically viable candidate. The scope includes iterative cycles of library screening, functional characterization, and structural optimization to enhance target binding while minimizing off-target interactions, ensuring the final product meets stringent performance benchmarks. This subcontract is issued under the NAICS code 541714 for research and development in the biological sciences and is associated with the National Institutes of Health through the Department of Health and Human Services. The place of performance is in Bethesda, Maryland, with a deadline for proposals set for July 31, 2026. The contract is expected to support biomedical innovation targeting receptor-mediated delivery systems and requires expertise in molecular biology, high-throughput screening, and protein engineering. No specific set-aside provisions are indicated, and the work is open to qualified subcontractors capable of delivering scalable, data-driven antibody development solutions within the defined timeline.
National Institutes Of Health Olao

POSTED

5 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Develop and Validate Transferrin ReceptorThe National Institutes of Health, under the Department of Health and Human Services, has issued a presolicitation notice for the development and validation of a transferrin receptor, identified by solicitation number 75N98026Q00866. This opportunity is open for responses until July 31, 2026, and was posted on July 24, 2026, with no set-aside provisions applied, making it open to all eligible entities. The work will be performed in Bethesda, Maryland, and falls under the NAICS code 541714, which corresponds to research and development in the physical, engineering, and life sciences. The primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. Interested parties are directed to the official SAM.gov workspace link for further details and submission guidelines. The contract aims to support advanced scientific research focused on the transferrin receptor, likely to advance biomedical applications or therapeutic technologies. All proposals must adhere to the requirements outlined in the notice of intent, and submissions should be prepared with consideration for the technical scope, timeline, and performance standards expected by the NIH Office of Laboratory Animal Welfare. The contract is structured to enable innovation in molecular biology or drug delivery systems involving receptor targeting, with performance expected within the confines of federal research protocols and compliance standards.
National Institutes Of Health Olao

POSTED

5 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakThe Food and Drug Administration is planning to award a sole source firm-fixed price purchase order to The University of Liverpool under simplified acquisition procedures for the sequencing of Bundibugyo virus disease during the 2026 outbreak, relying on FAR Part 6.103-1 which permits non-competitive procurement when only one responsible source exists. This action falls under the NAICS code 541714 for Research and Development in Biotechnology and is not open for competitive bidding, as the FDA has determined that The University of Liverpool is the only entity with the necessary expertise and capacity to meet the technical requirements for this highly specific viral sequencing effort. The contract is intended to support bioanalytical method development and sample analysis by providing critical reagents and reference standards for quantifying CYP enzyme substrates and metabolites in hepatocyte experiments during the outbreak response. Responses to this notice must be submitted by Ryan Alexander at ryan.alexander@fda.hhs.gov no later than 5:00 pm on July 29, 2026, and must include a detailed capability statement for any other organization seeking consideration, though the government retains full discretion to determine whether a response justifies competitive solicitation. The procurement is not a request for competitive quotes, and no set-aside is being applied. The contract will be administered from the FDA’s office in Rockville, Maryland, with performance primarily occurring in Liverpool, England, and the solicitation number is OC-2026-135667, issued on July 24, 2026.
Food And Drug Administration

POSTED

5 days ago

DEADLINE

in about 14 hours
View Details
NAICS: 541714
New
Federal
Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic testThe Centers for Disease Control and Prevention is soliciting bids for the procurement of 4,000 lateral flow strips intended for use in a rapid HIV nucleic acid diagnostic test under a firm-fixed-price contract, issued as a Request for Quote in accordance with FAR Subpart 12 for commercial items. The solicitation number is 75D30126Q79099, with a performance period of August 1, 2026, to December 31, 2026, and an option to extend services for up to six additional months. Proposals must be submitted electronically to Eugene Gutierrez at zvm0@cdc.gov no later than 3:00 P.M. Eastern Standard Time on Friday, July 24, 2026, with no telephonic or paper submissions accepted. The place of performance is the CDC facility at 1600 Clifton Road, Building 17, Atlanta, GA 30329-4018. Offerors must be registered in the System for Award Management at the time of submission and are required to comply with all applicable FAR clauses, including 52.212-1 and 52.212-4, along with deviations such as those addressing trafficking in persons, contractor employee whistleblower rights, sustainable products and services, Buy American Act alternatives for Israeli and Korean end products, and prohibitions on unauthorized information sharing. Technical evaluation is the predominant factor in award, emphasizing experience with biomedical devices, FDA approval processes, and prior work with lateral flow technology, with price considered secondary. The contractor must deliver 200 prototype strips and 4,000 final units meeting stringent performance standards: ≤0.5% false positive rate and ≤1% false negative rate using CDC’s LAMP reaction, and must ensure full compatibility with CDC’s mass production protocols. All deliverables must conform to Section 508 accessibility requirements, including WCAG 2.0 Level AA, and vendors must provide a Voluntary Product Accessibility Template or HHS conformance checklist. The contract imposes strict security and confidentiality obligations, including mandatory non-disclosure agreements for all employees accessing sensitive information, identification protocols to distinguish contractor personnel from government staff, and prohibitions against retaining or disseminating federal records or Privacy Act data. Subcontractors must be bound by the same requirements, and all payments must be processed via the Treasury’s Invoice Processing Platform using an ACH Vendor Enrollment
CDC Office Of Acquisition Services

POSTED

5 days ago

DEADLINE

in about 13 hours
View Details

More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)

Same awarding agency

NAICS: 541611
New
Federal
Regulatory Strategy and FDA Alignment ConsultingThe contract seeks specialized consulting services to develop and implement a regulatory strategy aligned with FDA quality assurance standards, ensuring that system outputs are positioned for successful approval or adoption under applicable regulatory pathways. The work focuses on providing expert guidance to navigate the complexities of federal regulatory requirements, with particular emphasis on health technology systems undergoing evaluation by the Food and Drug Administration. The contractor must demonstrate a deep understanding of FDA processes, including validation, documentation, and compliance frameworks, to support the development of defensible, scalable, and FDA-ready solutions. This subcontract is issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services, with a place of performance in Washington DC, 20005. The opportunity is classified under NAICS code 541611 for management consulting services and is open for responses until August 20, 2026. While no specific set-aside designation is provided, the solicitation is structured to attract qualified entities capable of delivering strategic regulatory advisory services to federal health innovation initiatives. The contract aims to accelerate the translation of advanced health technologies into clinically adopted solutions by embedding regulatory compliance early and systematically into the development lifecycle.
Administrative Management and General Management Consulting Services

POSTED

about 19 hours ago

DEADLINE

in 22 days
View Details
NAICS: 541715
New
Federal
AI/ML Models for Drug Composition VerificationThe contract seeks the development of advanced machine learning algorithms to non-invasively verify drug identity, detect contaminants, and identify substandard pharmaceutical formulations by analyzing multi-sensor data without requiring penetration of the container. This effort is focused on creating robust AI models capable of interpreting complex sensor inputs to ensure drug quality and safety, supporting regulatory and public health objectives through innovative, contactless analysis. The work must be completed within a strict timeline, with proposals due by August 20, 2026, and is classified as a subcontract under NAICS code 541715, indicating a focus on research and development in the physical, engineering, and life sciences. The contracting agency is the Advanced Research Projects Agency for Health, part of the U.S. Department of Health and Human Services, and the performance location is designated as Washington, D.C. with a ZIP code of 20005. While no set-aside provisions or specific point of contact are provided, the solicitation emphasizes technological innovation in pharmaceutical verification, targeting solutions that enhance supply chain integrity and public health outcomes. The absence of a solicitation number and detailed office address suggests this may be an internal or pre-solicitation notice, but the clear deadline and agency affiliation indicate active planning for future contracting actions.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 19 hours ago

DEADLINE

in 22 days
View Details
NAICS: 541715
New
Federal
Intelligent Generator of Research (IGoR) - ISOThe Intelligent Generator of Research (IGoR) program, issued under solicitation ARPA-H-SOL-26-155 by the Advanced Research Projects Agency for Health (ARPA-H), aims to revolutionize biomedical research by building an AI-enabled interoperable ecosystem that accelerates the development of therapies for complex diseases. Designed as a five-year, three-phase initiative, IGoR seeks to create a closed-loop system comprising mechanistic disease models that capture causal biological relationships across scales, an AI orchestration layer that identifies knowledge gaps and designs optimal experiments, a standardized, reproducible protocol architecture accessible to any qualified lab, and a distributed marketplace of validated laboratories that execute these protocols and return high-quality data. Together, these components aim to produce validated scientific knowledge at least ten times faster than conventional methods, enabling researchers to pursue bold, unconventional directions currently hindered by inefficiency. The program operates under an Other Transaction (OT) Agreement framework governed by a Draft Model OT Agreement, with all terms subject to negotiation by the Government Agreements Officer, and is authorized under 42 U.S.C. § 290c(g)(1)(D). Proposals must fully address four technical areas across all three phases, with Phase III requiring the expansion of the system to a second disease area, operation of a unified experiment marketplace, and public release of all computational artifacts. Proposals must be submitted via the ARPA-H Solutions portal by the extended deadline of August 6, 2026, and must conform to strict formatting guidelines, including English language, 11-point sans-serif font, and 1-inch margins on 8.5 x 11-inch pages. Proposers must register in SAM.gov with an active Unique Entity Identifier (UEI) and designate an Electronic Business Point of Contact, and must include a fully burdened Basis of Estimate covering direct labor, equipment, travel, other direct costs, indirect costs, and profit/fee, with all resource sharing integrated into the total proposed cost. The evaluation will prioritize overall scientific and technical merit, proposer capability, relevance to ARPA-H’s mission, and cost reasonableness, with no fixed weights assigned. Performance is milestone-driven, with payments tied to government verification of successful completion, requiring detailed Task Description Documents (TDDs) specifying quantitative performance criteria. All deliverables must be submitted on schedule and maintained for audit for up to three years post-award. The agreement imposes critical restrictions including prohibition on Covered Telecommunications Equipment under Public Law 115
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 19 hours ago

DEADLINE

in 15 days
View Details
NAICS: 541715
New
Federal
Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING)The Advanced Research Projects Agency for Health (ARPA-H) is issuing a solicitation under number ARPA-H-SOL-26-154 for the Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy (HEARING) Program, targeting innovative neurotechnological solutions aimed at restoring hearing by intervening in the auditory cortex rather than the ear. The program seeks to develop a closed-loop system that records neural activity from the auditory cortex, dynamically modulates incoming sound in real time, and writes back missing auditory information through targeted stimulation. This effort is structured around three tightly integrated Technical Areas: TA1 involves creating minimally invasive intracortical devices with recording and stimulation capabilities; TA2 focuses on developing a wearable, wirelessly powered dynamic sound modulator; and TA3 requires designing real-time neurocomputational algorithms for decoding and encoding auditory signals, integrated with clinical neurology and audiology expertise. All three components must combine into a single, functional platform over a multi-phase development timeline with increasing complexity, with performance evaluated based on milestone achievement and intermediate metrics. Proposals must be submitted electronically via the ARPA-H Solution Submission Portal following strict formatting guidelines outlined in the solicitation's appendices. A mandatory solution summary, compliant with Appendix A, must be submitted prior to a full proposal, which must adhere to the structure in Appendix B and include supporting documents from Appendices C through F, including a cost proposal model and administrative policy template for Other Transactions. Cost submissions require justification for expenses above $15,000 with supporting documentation, and all proposals must include an updated Gantt chart reflecting project timelines. The solicitation mandates active SAM.gov registration, prohibits entities from covered foreign countries, foreign entities of concern, malign foreign talent recruitment participants, suspended or debarred firms, and federally funded research centers or government employees from participating as primes or subs. Proposers must comply with stringent data handling protocols for Controlled Unclassified Information, mark proprietary data clearly as “Proprietary” (not “Confidential”), and adhere to human and animal subject research regulations under 45 CFR § 46, 21 CFR § 56, 9 CFR parts 1–4, and the Public Health Service Policy. Invoicing must be processed through Payment Management Services with a standardized 1,000-character justification for each payment tied to accepted milestones. Evaluations prioritize scientific and technical merit, proposer capability, potential impact on ARPA-H’s mission, and cost realism, with awards expected to be issued
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

in 16 days
View Details
NAICS: 541715
Federal
Restorative and health-Enhancing Sleep Time (REST)The Advanced Research Projects Agency for Health (ARPA-H) is soliciting innovative proposals under the Restorative and health-Enhancing Sleep Time (REST) program to revolutionize sleep health through objective, home-based, closed-loop technologies that detect and respond to sleep microstructures in real time. The program aims to reduce by at least 50% the 10-year risk of chronic diseases linked to poor sleep—including dementia, depression, cardiovascular disease, and type 2 diabetes—by developing validated systems that measure, diagnose, and treat sleep dysfunction with precision. The technical scope is divided into two areas: Technical Area 1 (TA1) focuses on creating in-home systems for objective measurement and mechanistic classification of poor sleep using physiological signals, while Technical Area 2 (TA2) targets the development of integrated, noninvasive, closed-loop interventions that adapt in real time to individual sleep physiology to improve outcomes. The program is structured into three phased milestones over 66 months—Prove Tech (24 months), Proof-of-Concept (18 months), and Translation (24 months)—with specific technical benchmarks including AUC thresholds for insomnia diagnosis, sensitivity/specificity targets for sleep classification, and Pearson correlation standards for fidelity to polysomnography. Key milestones include IRB approvals by month 3, human subject enrollment by month 12, technology validation and FDA submissions by month 39, and final site visits and demonstrations between months 63 and 66. Proposals must be submitted in two stages: a Solution Summary, due by August 12, 2026, at 12pm ET, and a Full Proposal for those invited to proceed. The Solution Summary must be submitted via https://solutions.arpa-h.gov/events, adhere to strict formatting rules including 12-point Avenir Next LT Pro font, and comply with page limits of six pages for single TA or eight pages for both TAs, excluding cover pages, basis of estimate, cost share strategy, and citations. Only invited proposers may submit a Full Proposal, which includes an in-person pitch—45 minutes for one TA or 60 minutes for both—and supporting documentation divided into five volumes: a four-page Technical Proposal, an unrestricted Cost/Price Proposal, a two-page Human or Animal Subjects Research section, a Data Management and Security Plan, and up to five pages of qualifications per key personnel. Evaluation is based on scientific and technical merit, feasibility, innovation, proposer capability, and budget
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

in 14 days
View Details
NAICS: 541715
Federal
Technology InteGrator and AcceleratoR (TIGAR)The Technology InteGrator and AcceleratoR (TIGAR) solicitation, issued by the Advanced Research Projects Agency for Health (ARPA-H) under number ARPA-H-SOL-26-144, seeks innovative solutions to enable temperature-flexible storage of complex regenerative tissues and organs, removing reliance on strictly controlled cryogenic conditions. The effort targets functional preservation of organoids, donated tissues, whole organs, or one-cubic-centimeter tissue volumes for at least 30 days at practical temperatures: -80°C, -20°C, 4°C, or 20°C–25°C room temperature, using novel combinations of materials, AI/ML, high-throughput screening, biological interventions, devices, or packaging approaches. The project is structured as an 18-month period of performance divided into two nine-month phases, with a down-select decision at the end of Phase 1. Proposals must align with HHS health IT standards, promote open-source software licensing (MIT, BSD, Apache 2.0), enhance data interoperability, and avoid low-risk or junior-staffed approaches designed solely for cost appearance. Funding is capped at $2 million per award, and only proposals submitted through the ARPA-H Solution Submission Portal will be considered. The solicitation allows multiple Other Transaction (OT) agreements and does not use a set-aside. Submission follows a two-step process: first, a 7-minute Solution Video with a transcript and supplemental slides, and second, a Full Proposal including technical, management, cost, and administrative documentation. The Solution Video deadline for Intake Group 1 has been amended to August 12, 2026, with the Full Proposal deadline extended to September 17, 2026; Intake Group 2 deadlines remain December 8, 2026, and February 5, 2027, respectively. All materials must be submitted via the ARPA-H portal, in English, using sans-serif 11-point fonts, with file names free of spaces or symbols. Evaluation prioritizes scientific and technical merit, proposer capabilities, alignment with ARPA-H’s mission and user needs, and cost realism. Proposal teams must hold valid SAM.gov registrations with active UEIs, provide good faith representations of intellectual property ownership, disclose organizational conflicts of interest, and ensure compliance with federal research security regulations, including prohibitions against involvement with malign foreign talent programs or entities of concern under the CHIPS and
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

16 days ago

DEADLINE

in 6 months
View Details
NAICS: 541715
Federal
Brain Repair of Any Injured Neural Structure (BRAINS)The Advanced Research Projects Agency for Health (ARPA-H) is seeking innovative solutions through the Brain Repair of Any Injured Neural Structure (BRAINS) Exploratory Topic program under solicitation ARPA-H-SOL-26-148, which utilizes Other Transaction (OT) agreements rather than standard federal contract mechanisms. The program aims to advance technologies capable of restoring function to damaged brain regions—specifically targeting areas such as the hippocampus, amygdala, thalamus, hypothalamus, striatum, cingulate cortex, substantia nigra, brainstem, and cerebellum—by generating and engrafting region-specific precursor tissue, while explicitly excluding the neocortex and spinal cord as well as conventional cell or organoid-based approaches. Proposers must submit a mandatory solution summary prior to full proposal submission, with two intake cycles: the first requiring solution summaries by July 9, 2026, and full proposals by August 6, 2026; the second, with deadlines of January 7, 2027, and February 6, 2027, respectively. Proposals must be submitted via the ARPA-H Solution Submission Portal and must conform to a strict three-volume structure: Volume I (Technical and Management Proposal with a 10-page limit for core content), Volume II (Cost Proposal using the ARPA-H Standard Excel Spreadsheet and supporting narrative), and Volume III (Administrative and Policy Requirements including certifications for organizational conflicts of interest, research security, biosecurity, cyber practices, animal research approvals, and tax compliance). Awardees will be evaluated based on the scientific and technical merit of the approach, the proposer’s expertise, potential for clinical and commercial impact aligned with ARPA-H’s mission, and the reasonableness of the proposed cost, with no preset weighting but ranked in descending importance. Phase I awards are anticipated at $500,000 per team with optional Phase II funding up to an additional $500,000, subject to successful technical milestones and budgetary compliance. Financial administration requires registration and invoice submission via the Payment Management Services (PMS) portal, with detailed justifications for each payment tied to specific milestones or TDD tasks, and salary support for individuals is capped at the Executive Level II rate set by the Office of Personnel Management. All awarded work must occur in the United States, with priority given to domestic entities, and proposers must confirm compliance with national security
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

27 days ago

DEADLINE

in 7 months
View Details